WASHINGTON, Jan 30 (Reuters) - Biopharmaceutical company Iomai Corp. on Monday cut its planned initial public offering to 5 million shares at $7 to $9 each from 6.25 million at between $11 and $13.
WASHINGTON, Jan 30 (Reuters) - Biopharmaceutical company Iomai Corp. on Monday cut its planned initial public offering to 5 million shares at $7 to $9 each from 6.25 million at between $11 and $13.